NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. (Q36336051)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. |
scientific article |
Statements
NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes (English)
Zhi-Cheng Gong
Qiong Huang
Xing-Ping Dai
Guang-Hua Lei
Hong-Bin Lu
Xiao-Jing Xu
Jian Qu
Qi Pei
Min Dong
Bo-Ting Zhou
Jie Shen
Gan Zhou
Hong-Hao Zhou
1 September 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference